Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Safety risks were cited previously When the FDA added a number of injectable peptides to its list of restricted substances in 2023, it cited safety risks including cancer and liver, kidney and heart problems
Efficacy Evidence in Older Adult Populations A subset analysis from the SUSTAIN trials (semaglutide for type 2 diabetes) showed adults aged 65+ achieved mean weight reductions of 4-8 kg over 56 weeks on semaglutide 1 mg weekly, with similar relative improvements to younger participants
Effect on Efficacy: Ultimately, an effective peptide is one that retains its biological activity and solubility until you use it
What to know Most side effects appear early in treatment and usually improve as your body adjusts to the dose
How to Rotate Properly: Switch Body Areas: Inject your stomach one week, and your thigh the next
